Immunis.AI
Immunis.AI is a biotechnology company that has developed a patented platform for cancer detection using the immune system response as a diagnostic biomarker. The company Intelligentia platform combines machine learning with disease-specific algorithms to analyze RNA expression changes triggered by the immune system rapid reaction to threats. Because the immune system amplifies its response internally, even small…
Funding snapshot
About
Immunis.AI is a biotechnology company that has developed a patented platform for cancer detection using the immune system response as a diagnostic biomarker. The company Intelligentia platform combines machine learning with disease-specific algorithms to analyze RNA expression changes triggered by the immune system rapid reaction to threats. Because the immune system amplifies its response internally, even small threats produce measurable changes in RNA expression that can be detected through blood samples. This approach enables early cancer detection by leveraging the natural amplification structure of immune responses, potentially identifying cancers before symptoms appear or imaging detects tumors. The platform is designed to develop diagnostic tests across multiple cancer types. Founded in 2012 and headquartered in Royal Oak, Michigan, Immunis.AI has raised $40 million through Series C funding from investor Savitr Capital.
Business model
Oncology > In-Vitro Diagnostic Tests > Prostate Cancer,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Liquid Biopsy > RNA
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.